XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2012
Jun. 30, 2011
CURRENT ASSETS:    
Cash and cash equivalents $ 11,605 $ 42,829
Short term bank deposits 21,896   
Marketable securities 6,042   
Prepaid expenses 172 314
Accounts receivable from the Office of the Chief Scientist 1,529   
Other accounts receivable 211 154
Total current assets 41,455 43,297
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 695 179
Severance pay fund 525 452
Advance payment for leasehold improvements 1,155   
Property and equipment, net 3,066 2,088
Total long-term assets 5,441 2,719
Total assets 46,896 46,016
CURRENT LIABILITIES    
Trade payables 1,529 1,177
Accrued expenses 230 208
Deferred revenues 923   
Advance payment from United Therapeutics 1,509   
Other accounts payable 663 633
Total current liabilities 4,854 2,018
LONG-TERM LIABILITIES    
Deferred revenues 3,462   
Accrued severance pay 679 576
Total long-term liabilities 4,141 576
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Common stock $0.00001 par value: Authorized: 100,000,000 shares Issued and outstanding: 44,516,175 shares as of March 31, 2012, 42,443,185 shares as of June 30, 2011      
Additional paid-in capital 99,461 94,375
Accumulated deficit (61,612) (50,953)
Other comprehensive gain 52   
Total stockholders' equity 37,901 43,422
Total liabilities and stockholders' equity $ 46,896 $ 46,016